Mr. Cheng Wang is Venture Partner of Co-win Ventures, focusing on healthcare investment. He has over 10 years research experience in molecular biology and virology and he successfully founded Innovec Biotherapeutics. Prior to joining Co-win Ventures, He was Founding Scientist of Viral Vector Technology department of Regeneron Pharmaceuticals and helped Regeneron combine their antibody technologies to build up pipelines of gene and cell therapy. Mr. Wang has obtained 7 patents which build up the gene therapy intellectual property of Regeneron.
      From 2019 to 2021, Mr. Wang was Investment Director of Co-win Ventures.
Mr. Wang holds a Ph.D. in Biological Sciences from Columbia University and a B.S. in Biological Sciences from Tsinghua University. His doctoral research works have been published in PNAS and Nature Structural and Molecular Biology.